
Glenmark Pharmaceuticals Limited (GLENMARK)
NSEINR 1830.42.63%
Price Chart
Key Statistics
Market Cap
INR 519.56B
P/E Ratio
49.52
Revenue (TTM)
INR 134.35B
Volume
814.81K
52W High
INR 1843.30
52W Low
INR 1275.50
Dividend Yield
0.14%
Beta
0.20
Technicals
50-Day MA
1537.272
200-Day MA
1524.3268
52 Week High
1843.3
52 Week Low
1275.5
About GLENMARK
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America.
Employees
N/A
Headquarters
Mumbai, India
CEO
Mr. Glenn Mario Saldanha
Latest News
Glenmark gets five observations from USFDA for Monroe plant - The Economic Times
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg